5901 |
8CWK |
HL_C |
4G1-C2 Fab |
SARS-CoV-2 spike glycoprotein RBD |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
XRD |
2.37 | Not available or To be published |
5902 |
8CWK |
AB_C |
10G4 Fab |
SARS-CoV-2 spike glycoprotein RBD |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
XRD |
2.37 | Not available or To be published |
5903 |
8CWU |
B_A |
1-21 VHH |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
1.71 | 10.1016/j.celrep.2022.111004 |
5904 |
8CWV |
HL_A |
CC12.1 Fab |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Lama glama, Homo sapiens |
XRD |
2.51 | 10.1016/j.celrep.2022.111004 |
5905 |
8CWV |
B_A |
2-31 VHH |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Lama glama, Homo sapiens |
XRD |
2.51 | 10.1016/j.celrep.2022.111004 |
5906 |
8CXC |
HL_M |
3F2 Fab |
Human mesothelin |
Mus musculus, Homo sapiens |
XRD |
4.31 | 10.3389/fddsv.2023.1216516 |
5907 |
8CXC |
A_M |
Amatuximab scFv |
Human mesothelin |
Mus musculus, Homo sapiens |
XRD |
4.31 | 10.3389/fddsv.2023.1216516 |
5908 |
8CXN |
D_A |
2-57 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
2.9 | 10.1016/j.celrep.2022.111004 |
5909 |
8CXN |
E_B |
2-57 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
2.9 | 10.1016/j.celrep.2022.111004 |
5910 |
8CXN |
F_C |
2-57 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
2.9 | 10.1016/j.celrep.2022.111004 |
5911 |
8CXQ |
D_A |
1-22 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
2.3 | 10.1016/j.celrep.2022.111004 |
5912 |
8CXQ |
E_B |
1-22 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
2.3 | 10.1016/j.celrep.2022.111004 |
5913 |
8CXQ |
F_C |
1-22 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
2.3 | 10.1016/j.celrep.2022.111004 |
5914 |
8CY6 |
D_A |
2-65 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
3.2 | 10.1016/j.celrep.2022.111004 |
5915 |
8CY6 |
E_B |
2-65 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
3.2 | 10.1016/j.celrep.2022.111004 |
5916 |
8CY6 |
F_C |
2-65 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
3.2 | 10.1016/j.celrep.2022.111004 |
5917 |
8CY7 |
D_A |
2-38 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
2.9 | 10.1016/j.celrep.2022.111004 |
5918 |
8CY7 |
E_B |
2-38 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
2.9 | 10.1016/j.celrep.2022.111004 |
5919 |
8CY7 |
F_C |
2-38 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
2.9 | 10.1016/j.celrep.2022.111004 |
5920 |
8CY9 |
D_A |
1-23 VHH |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
2.9 | 10.1016/j.celrep.2022.111004 |